URGN Forecast and Technical Stock Analysis
Sell candidate since 2019-09-20 Loss -35.70% PDF
UroGen Pharma Ltd gained 1.17% in the last trading day ( Thursday, 17th Oct 2019 ), rising from $22.15 to $22.41 During the day the stock fluctuated 2.41% from a day low at $22.23 to a day high of $22.76. The price has fallen in 5 of the last 10 days and is down by -5.36% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 45 788 more shares were traded than the day before. In total, 121 621 shares bought and sold for approximately $2.73 million.
- 30 day high of the URGN stock price was $36.57 and low was $20.72.
- 90 day high was $37.08 and low was $20.72.
- 52 week high for UroGen Pharma Ltd - $55.49 and low - $20.72.
UroGen Pharma Ltd lies in the lower of a very wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $20.15 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -23.85% during the next 3 months and, with 90% probability hold a price between $15.34 and $24.98 at the end of this period.
A buy signal was issued from a pivot bottom point on Wednesday October 09, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. UroGen Pharma Ltd holds a buy signal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $28.73. On a fall, the stock will find some support from the short-term average at $21.71. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 39 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
UroGen Pharma Ltd finds support from accumulated volume at $21.76.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.54 between high and low, or 2.41%. For the last week, the stock has had a daily average volatility of 3.93%.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
3.93 %Average volatility
Very Low Low Medium High Very High
|URGN $22.41 ($0.26 1.17%)|
URGN is up $0.26 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for URGN based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the URGN analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!